TY - JOUR
T1 - Protective Factors against Fear of Cancer Recurrence in Breast Cancer Patients
T2 - A Latent Growth Model
AU - on behalf of the BOUNCE Consortium
AU - Bentley, Gabriella
AU - Zamir, Osnat
AU - Dahabre, Rawan
AU - Perry, Shlomit
AU - Karademas, Evangelos C.
AU - Poikonen-Saksela, Paula
AU - Mazzocco, Ketti
AU - Sousa, Berta
AU - Pat-Horenczyk, Ruth
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/9/15
Y1 - 2023/9/15
N2 - The current study aimed to examine the fear of cancer recurrence (FCR) trajectory and protective predictors in women coping with breast cancer (BC). The study’s model investigated whether a higher coping self-efficacy and positive cognitive–emotion regulation at the time of the BC diagnosis would lead to reduced levels of FCR at six months and in later stages (12 and 18 months) post-diagnosis. The sample included 494 women with stages I to III BC from Finland, Italy, Portugal, and Israel. They completed self-report questionnaires, including the Fear of Cancer Recurrence Inventory (FCRI-SF), the Cancer Behavior Inventory-Brief Version (CBI-B), the Cognitive–Emotion Regulation Questionnaire (CERQ short), and medical–social–demographic data. Findings revealed that a higher coping self-efficacy at diagnosis predicted lower FCR levels after six months but did not impact the FCR trajectory over time. Surprisingly, positive cognitive–emotion regulation did not predict FCR levels or changes over 18 months. FCR levels remained stable from six to 18 months post-diagnosis. This study emphasizes the importance of developing specific cancer coping skills, such as coping self-efficacy. Enhancing coping self-efficacy in the first six months after BC diagnosis may lead to lower FCR levels later, as FCR tends to persist in the following year.
AB - The current study aimed to examine the fear of cancer recurrence (FCR) trajectory and protective predictors in women coping with breast cancer (BC). The study’s model investigated whether a higher coping self-efficacy and positive cognitive–emotion regulation at the time of the BC diagnosis would lead to reduced levels of FCR at six months and in later stages (12 and 18 months) post-diagnosis. The sample included 494 women with stages I to III BC from Finland, Italy, Portugal, and Israel. They completed self-report questionnaires, including the Fear of Cancer Recurrence Inventory (FCRI-SF), the Cancer Behavior Inventory-Brief Version (CBI-B), the Cognitive–Emotion Regulation Questionnaire (CERQ short), and medical–social–demographic data. Findings revealed that a higher coping self-efficacy at diagnosis predicted lower FCR levels after six months but did not impact the FCR trajectory over time. Surprisingly, positive cognitive–emotion regulation did not predict FCR levels or changes over 18 months. FCR levels remained stable from six to 18 months post-diagnosis. This study emphasizes the importance of developing specific cancer coping skills, such as coping self-efficacy. Enhancing coping self-efficacy in the first six months after BC diagnosis may lead to lower FCR levels later, as FCR tends to persist in the following year.
KW - BOUNCE
KW - breast cancer
KW - coping self-efficacy
KW - fear of cancer recurrence
KW - latent growth modeling
KW - trajectories
UR - http://www.scopus.com/inward/record.url?scp=85172937046&partnerID=8YFLogxK
U2 - 10.3390/cancers15184590
DO - 10.3390/cancers15184590
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37760558
AN - SCOPUS:85172937046
SN - 2072-6694
VL - 15
JO - Cancers
JF - Cancers
IS - 18
M1 - 4590
ER -